Picard Medical, Inc.
PMI
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.91M
Close$
$-0.38
106.6% downside
Current Fair Value
106.6% downsideOvervalued by 106.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.91 Million |
|---|---|
| Enterprise Value | $12.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-18.5 |
| Beta | -2.64 |
| Outstanding Shares | 1,855,813 |
Return
| Return on Equity | -1631.18% |
|---|---|
| Return on Assets | -305.35% |
| Return on Invested Capital | -892.02% |
Valuation & Multiples
| P/E Ratio | -0.28 |
|---|---|
| PEG | 1.14 |
| Price to Sales | 1.93 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.02 |
| Enterprise Value to EBIT | -0.83 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 10, 2026
EPS Estimate
$-1.50
Average shareholder expectationRevenue Estimate
$1.55 M
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-1.50
Average shareholder expectationRevenue Estimate
$1.55 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.20%▲ 7.67% |
|---|---|
| Total Invested | $1.24M▲ 202.27% |
| Investors Holding | 40▼ 1.00% |
ESG Score
No data
About Picard Medical, Inc.
75 employees
CEO: Patrick N. J. Schnegelsberg Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is desig...